Modification of selected anti-hcmv drugs with lipophilic boron cluster modulator

Acta Poloniae Pharmaceutica - Drug Research

Volumn 70, Issue 3, 2013, Pages 489-504

  Olejniczak, Agnieszka B ^a   Adamska, Anna M ^a   Paradowska, Edyta ^a   Studzinska, Mirosława ^a   Suski, Patrycja ^a   Leśnikowski, Zbigniew J ^a  

^a INSTITUTE OF MEDICAL BIOLOGY   (Poland)

Author keywords

Anti HCMV drugs; Boron clusters; Nucleosides

Indexed keywords

ACICLOVIR DERIVATIVE; ANTIVIRUS AGENT; BORON; CIDOFOVIR DERIVATIVE; GANCICLOVIR DERIVATIVE; UNCLASSIFIED DRUG; VALGANCICLOVIR DERIVATIVE;

ADHERENT CELL; ANTIVIRAL ACTIVITY; ARTICLE; CONTROLLED STUDY; CYTOPATHOGENIC EFFECT; CYTOTOXICITY TEST; DRUG HALF LIFE; DRUG STABILITY; EMBRYO; HUMAN; HUMAN CELL; LIPOPHILICITY; REDUCTION;

ANIMALS; ANTIVIRAL AGENTS; BORON; CELL LINE; CYTOMEGALOVIRUS; DRUG STABILITY; HUMANS; SOLUBILITY; STEREOISOMERISM;

EID: 84878084073     PISSN: 00016837     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (40)

1. Pass R.F.: in Fields Virology, Knipe D.M., Howley P.M., Griffin D.E., Lamb R.A., Martin M.A, Roizman B., Strauss S.E. Eds., p. 2675, Lippincott Williams & Wilkins, Philadelphia 2001.
2. Griffiths P.D., Walter S.: Curr. Opin. Infect. Dis. 18, 241 (2005).
3. Toorkey C. B., Carrigan D. R.: J. Infect. Dis. 160, 741 (1989).
4. Dollard S. C., Grosse S. D., Ross D.S.: Rev. Med. Virol. 17, 355 (2007).
5. Cope A.V., Sweny P., Sabin C., Rees L., Griffiths P.D., Emery V.C.: J. Med. Virol. 52, 200 (1997).
6. Emery V.C., Cope A.V., Bowen E.F., Gor D., Griffiths P.: J. Exp. Med. 190, 177 (1999).
7. Mercorelli B., Sinigalia E., Loregian A., Palu G.: Rev. Med. Virol. 18, 177 (2008).
8. Villarreal E.C.: Prog. Drug Res. 60, 263 (2003).
9. Kimberlin D.W., Lin C.Y., Sanchez P.J., Demmler G.J. Dankner W., Shelton M., Jacobs R. F. et al., National Institute of Allergy and Infectious Diseases Collaborative Antiviral Study Group: J. Pediatr. 143, 16 (2003).
10. Amir J., Wolf D.G., Levy I. : Eur. J. Pediatr. 169, 1061 (2010).
11. Nassetta L., Kimberlin D., Whitley R.: J. Antimicrob. Chemother. 63, 862 ( 2009).
12. Yamamoto K., Endo Y.: Bioorg. Med. Chem. Lett. 11, 2389 (2001).
13. Schwyzer R., Do H.Q., Eberle A. N., FauchEre J. L.: Helv. Chim. Acta 64, 2078 (1981).
14. Lesnikowski Z.J.: Coll. Czech. Chem. Commun. 72, 1646 (2007).
15. Graciet J.C., Shi J., Schinazi R.F.: Nucleosides Nucleotides 17, 711 (1998).
16. Lesnikowski Z.J., Shi J., Schinazi R.F.: J. Organomet. Chem. 581, 156 (1999).
17. Matthews T., Boehme R.: Rev. Infect. Dis. 10 supl. 3, S490 (1988).
18. Ti G.S., Gaffney B. ., Jones R.A.: J. Am. Chem. Soc. 104, 1316 (1982).
19. Schaller H., Weimann B., Lerch B., Khorana H.G.: J. Am. Chem. Soc. 85, 3821 (1963).
20. Stawinski J., Str̂mberg R.: in Methods in Molecular Biology. Oligonucleotide Synthesis: Methods and Applications, Herdewijn P. Ed., p.81, vol. 288, Humana Press Inc., Totowa 2005.
21. Malmquist J., Sjoberg S.: Tetrahedron 52, 9207 (1996).
22. Galegov G.A., Shobukhov V.M., Leontieva N.A., Yasiko M.V.: Bioorg. Khim. 23, 906 (1997).
23. Krecmerova M., Holy A., Pohl R., Masojidkova M., Andrei G., Naesens L., Neyts J. et al.: J. Med. Chem. 50, 5765 (2007).
24. Erikssonz U., Hilfinger J.M., Kim J.S., Mitchell S., Kijek P., Borysko K.Z., Breitenbach J.M. et al.: Bioorg. Med. Chem. Lett. 17, 583 (2007).
25. Majumdar S., Nashed Y.E., Patel K., Jain R., Itahashi M., Neumann D.M., Hill J.M., Mitra A.K.: J. Ocul. Pharmacol. Ther. 21, 463 (2005).
26. Talluri R.S., Samanta S.K., Gaudana R., Mitra A.K.: Int. J. Pharm. 361, 118 (2008).
27. Nachman R.J., Teal P.E. A., Radel P.A., Holman G.E., Abernathy R.L.: Peptides 17, 747 (1996).
28. Rautio J., Kumpulainen H., Heimbach T., Oliyai R., Oh D., Jarvinen T., Savolainen J.: Nature Rev. 7, 255 (2008).
29. Beadle J.R., Hartline C., Aldern K.A., Rodriguez N., Harden E., Kern E.R., Hostetler K.Y.: Antimicrob. Agents Chemother. 46, 2381 (2002).
30. Hostetler K.Y., Beadle J.R., Kini G.D., Gardner M.F., Wright K.N., Wu T.H., Korba B.A.: Biochem. Pharmacol. 53, 1815 (1997).
31. Hostetler K.Y., Rybak R.J., Beadle J. R., Hartline C.B., Gardner M.F., Aldern K.A., Wright K.N., Kern E.R.: Antivir. Chem. Chemother. 11, 373 (2001).
32. Ruiz J.C., Beadle J.R., Aldern K.A., Keith K.A., Hartline C.B., Kern E.R., Hostetler K.Y.: Antivir. Res. 75, 87 (2007).
33. Wan W.B., Beadle J.R., Hartline C., Kern E.R., Ciesla S.L., Valiaeva N., Hostetler K.Y.: Antimicrob. Agents Chemother. 49, 656 (2005).
34. Wojtczak B., Olejniczak A. B., PrzepiUrkiewicz M., Andrysiak A., Lesnikowski Z. J.: Coll. Czech. Chem. Commun. 73, 175 (2008).
35. Kanetoz U., Fumitoshi H., Tetsumiz I. : Chem. Rev. 5, 2045 (1998).
36. Uchman M., Jurkiewicz P., Cigler P., Gruner B., Hof M., Prochazka K., Matejicek P.: Langmuir 26, 6268 (2010).
37. Bajda M., Boryczka S., Wietrzyk J., Malawska B.: Biomed. Chromatogr. 21, 123 (2007).
38. Lesnikowski Z.J., Paradowska E., Olejniczak A.B., Studzinska M., Seekamp P., Schfller U., Gabel D.et al.: Bioorg. Med. Chem. 13, 4168 (2005).
39. Berg K., Hansen M.B., Nielsen S.E.: APMIS 98, 156 (1990).
40. Freitas V.R., Fraser-Smith E.B., Matthews T.R.: Antivir. Res. 20, 1 (1993).